GlassScriptPhysician profile
Medhat Farwati
NPI 1104387182
$25,632.97
in general payments reported to CMS, 2019-2025
7 companies · $25K in 2025
The $25K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $771 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Travel and Lodging: $8,274 · Food and Beverage: $4,664 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Travel and Lodging | $8,274.22 |
| Food and Beverage | $4,664.40 |
| Education | $194.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,497.44 | 2024-2025 | Tacticath, Assurity, Gallant |
| Medtronic, INC. | $7,214.57 | 2024-2025 | Micra |
| Biosense Webster, INC. | $1,414.71 | 2025 | Carto 3 |
| Boston Scientific Corporation | $289.27 | 2025 | Ams 700, Accolade Sr |
| Medical Device Business Services, INC. | $216.98 | 2024 | Carto 3 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Medhat Farwati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.